September 2021

Morbidity and Mortality Committee

G. Ying Li

G. Ying Li, MD
Morbidity and Mortality Committee Chair

Members of the M&M committee have been working with the Platforms for Performance and Outcomes Task Force during the past year on strategies to refocus the committee to better serve the needs of the SRS membership. There are plans to rename the M&M committee to reflect the broader role of the committee, and its new focus on outcomes and benchmarking. The PPO Task Force has recommended creation of a SRS app that will have a number of features, including the ability for members to collect and submit data. Members will be asked to submit a minimum data set to allow for simple benchmarking and this will eventually replace the requirements to enter M&M data.

The M&M committee has also been working on a report of the 2013-2019 M&M data. The manuscript is near completion and will be submitted to Spine Deformity in the fall. Notable differences between this report and the previous report of 2009-2012 data include the cessation of collection of visual acuity loss data after 2015 and collection of unintentional return to the operating room data starting in 2017.

The 2020 M&M data was reviewed by the committee on our recent call. Overall, less cases were logged in 2020 compared to 2019 (40464 vs 48754 cases), likely due to decreased activity related to the COVID pandemic. Complication rates appeared similar between 2019 and 2020.

Stay tuned for future updates as the M&M Committee continues our transformation.

Committee Members: G. Ying Li (Chair), John France (Past Chair), Luis Munhoz Da Rocha (Chair Elect), Carlos Abreu de Aguiar, Ravi Bains, David Cohen, Lori Dolan, Emmanuelle Ferrero, David Gurd, Bachar Harfouche, Robert Huang, Konya, Jean-Marc Mac-Thiong, Vishal Sarwahi, Justin Seale, Sanjeev Suratwala, Kelly Vanderhave, Caglar Yilgor